vs
Astrana Health, Inc.(ASTH)与StoneX Group Inc.(SNEX)财务数据对比。点击上方公司名可切换其他公司
StoneX Group Inc.的季度营收约是Astrana Health, Inc.的1.3倍($1.2B vs $950.5M),StoneX Group Inc.净利率更高(11.6% vs 0.7%,领先10.9%),StoneX Group Inc.同比增速更快(81.0% vs 42.9%),Astrana Health, Inc.自由现金流更多($-6.0M vs $-1.3B),过去两年StoneX Group Inc.的营收复合增速更高(53.5% vs 53.3%)
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商,主要服务全美符合联邦医保资格的老年群体,提供上门初级护理、慢性病管理及护理协调服务,致力于提升患者健康水平、降低不必要的医疗支出。
StoneX集团是美国知名金融服务企业,核心业务覆盖商业套期保值、全球支付、证券、实物大宗商品、外汇,以及清算与执行服务六大板块,可为全球各类客户提供专业合规的多元化金融服务。
ASTH vs SNEX — 直观对比
营收规模更大
SNEX
是对方的1.3倍
$950.5M
营收增速更快
SNEX
高出38.2%
42.9%
净利率更高
SNEX
高出10.9%
0.7%
自由现金流更多
ASTH
多$1.3B
$-1.3B
两年增速更快
SNEX
近两年复合增速
53.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $950.5M | $1.2B |
| 净利润 | $6.6M | $139.0M |
| 毛利率 | — | — |
| 营业利润率 | 1.9% | 15.4% |
| 净利率 | 0.7% | 11.6% |
| 营收同比 | 42.9% | 81.0% |
| 净利润同比 | 184.4% | 63.3% |
| 每股收益(稀释后) | $0.12 | $2.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASTH
SNEX
| Q4 25 | $950.5M | $1.2B | ||
| Q3 25 | $956.0M | $32.7B | ||
| Q2 25 | $654.8M | $851.2M | ||
| Q1 25 | $620.4M | $820.4M | ||
| Q4 24 | $665.2M | $663.1M | ||
| Q3 24 | $478.7M | $31.1B | ||
| Q2 24 | $486.3M | $571.8M | ||
| Q1 24 | $404.4M | $509.2M |
净利润
ASTH
SNEX
| Q4 25 | $6.6M | $139.0M | ||
| Q3 25 | $373.0K | $85.7M | ||
| Q2 25 | $9.4M | $63.4M | ||
| Q1 25 | $6.7M | $71.7M | ||
| Q4 24 | $-7.8M | $85.1M | ||
| Q3 24 | $16.1M | $76.7M | ||
| Q2 24 | $19.2M | $61.9M | ||
| Q1 24 | $14.8M | $53.1M |
毛利率
ASTH
SNEX
| Q4 25 | — | — | ||
| Q3 25 | — | 3.7% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率
ASTH
SNEX
| Q4 25 | 1.9% | 15.4% | ||
| Q3 25 | 2.0% | 0.3% | ||
| Q2 25 | 3.1% | -1.3% | ||
| Q1 25 | 3.3% | -1.0% | ||
| Q4 24 | 0.1% | -3.2% | ||
| Q3 24 | 5.9% | -0.0% | ||
| Q2 24 | 6.2% | -4.7% | ||
| Q1 24 | 7.5% | -2.5% |
净利率
ASTH
SNEX
| Q4 25 | 0.7% | 11.6% | ||
| Q3 25 | 0.0% | 0.3% | ||
| Q2 25 | 1.4% | 7.4% | ||
| Q1 25 | 1.1% | 8.7% | ||
| Q4 24 | -1.2% | 12.8% | ||
| Q3 24 | 3.4% | 0.2% | ||
| Q2 24 | 3.9% | 10.8% | ||
| Q1 24 | 3.7% | 10.4% |
每股收益(稀释后)
ASTH
SNEX
| Q4 25 | $0.12 | $2.50 | ||
| Q3 25 | $0.01 | $0.72 | ||
| Q2 25 | $0.19 | $1.22 | ||
| Q1 25 | $0.14 | $1.41 | ||
| Q4 24 | $-0.14 | $1.69 | ||
| Q3 24 | $0.33 | $2.32 | ||
| Q2 24 | $0.40 | $1.25 | ||
| Q1 24 | $0.31 | $1.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $1.6B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $2.5B |
| 总资产 | $2.2B | $47.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ASTH
SNEX
| Q4 25 | $429.5M | $1.6B | ||
| Q3 25 | $463.4M | $1.6B | ||
| Q2 25 | $342.1M | $1.3B | ||
| Q1 25 | $260.9M | $1.3B | ||
| Q4 24 | $290.8M | $1.4B | ||
| Q3 24 | $350.3M | $1.3B | ||
| Q2 24 | $327.7M | $1.2B | ||
| Q1 24 | $337.3M | $1.3B |
股东权益
ASTH
SNEX
| Q4 25 | $779.3M | $2.5B | ||
| Q3 25 | $775.5M | $2.4B | ||
| Q2 25 | $765.5M | $2.0B | ||
| Q1 25 | $745.4M | $1.9B | ||
| Q4 24 | $712.7M | $1.8B | ||
| Q3 24 | $704.6M | $1.7B | ||
| Q2 24 | $678.9M | $1.6B | ||
| Q1 24 | $653.5M | $1.5B |
总资产
ASTH
SNEX
| Q4 25 | $2.2B | $47.8B | ||
| Q3 25 | $2.2B | $45.3B | ||
| Q2 25 | $1.4B | $34.3B | ||
| Q1 25 | $1.3B | $31.3B | ||
| Q4 24 | $1.4B | $29.6B | ||
| Q3 24 | $1.3B | $27.5B | ||
| Q2 24 | $1.3B | $25.9B | ||
| Q1 24 | $1.2B | $25.7B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $-1.3B |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $-1.3B |
| 自由现金流率自由现金流/营收 | -0.6% | -106.4% |
| 资本支出强度资本支出/营收 | 0.3% | 1.3% |
| 现金转化率经营现金流/净利润 | -0.44× | -9.08× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $3.5B |
8季度趋势,按日历期对齐
经营现金流
ASTH
SNEX
| Q4 25 | $-2.9M | $-1.3B | ||
| Q3 25 | $10.0M | $3.5B | ||
| Q2 25 | $90.9M | $1.5B | ||
| Q1 25 | $16.6M | $-154.5M | ||
| Q4 24 | $-10.9M | $-477.8M | ||
| Q3 24 | $34.0M | $192.6M | ||
| Q2 24 | $23.2M | $-622.1M | ||
| Q1 24 | $6.0M | $784.0M |
自由现金流
ASTH
SNEX
| Q4 25 | $-6.0M | $-1.3B | ||
| Q3 25 | $7.4M | $3.5B | ||
| Q2 25 | $89.5M | $1.5B | ||
| Q1 25 | $13.6M | $-169.8M | ||
| Q4 24 | $-13.5M | $-491.4M | ||
| Q3 24 | $31.7M | $175.9M | ||
| Q2 24 | $20.4M | $-640.5M | ||
| Q1 24 | $5.6M | $766.6M |
自由现金流率
ASTH
SNEX
| Q4 25 | -0.6% | -106.4% | ||
| Q3 25 | 0.8% | 10.7% | ||
| Q2 25 | 13.7% | 173.3% | ||
| Q1 25 | 2.2% | -20.7% | ||
| Q4 24 | -2.0% | -74.1% | ||
| Q3 24 | 6.6% | 0.6% | ||
| Q2 24 | 4.2% | -112.0% | ||
| Q1 24 | 1.4% | 150.5% |
资本支出强度
ASTH
SNEX
| Q4 25 | 0.3% | 1.3% | ||
| Q3 25 | 0.3% | 0.1% | ||
| Q2 25 | 0.2% | 1.9% | ||
| Q1 25 | 0.5% | 1.9% | ||
| Q4 24 | 0.4% | 2.1% | ||
| Q3 24 | 0.5% | 0.1% | ||
| Q2 24 | 0.6% | 3.2% | ||
| Q1 24 | 0.1% | 3.4% |
现金转化率
ASTH
SNEX
| Q4 25 | -0.44× | -9.08× | ||
| Q3 25 | 26.69× | 41.18× | ||
| Q2 25 | 9.65× | 23.52× | ||
| Q1 25 | 2.48× | -2.15× | ||
| Q4 24 | — | -5.61× | ||
| Q3 24 | 2.11× | 2.51× | ||
| Q2 24 | 1.21× | -10.05× | ||
| Q1 24 | 0.40× | 14.76× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
SNEX
暂无分部数据